Research Info

Home /A new 1D Mn(II) coordination ...
Title A new 1D Mn(II) coordination polymer: Synthesis, crystal structure, hirshfeld surface analysis and molecular docking studies
Type JournalPaper
Keywords Supramolecular chemistry. metal-organic coordination polymers (MOCP). solvothermal. sonochemical ultrasonic-assisted. density functional theory (DFT)
Abstract The synthesis of novel metal-organic coordination polymers (MOCP) with the chemical formula [Mn2L (SCN)2(OH)2]3·CH3OH [L = 1,5-bis(pyridine-4-ylmethylene) carbonohydrazide] {1} was accomplished using two different techniques: solvothermal and sonochemical ultrasonic-assisted. An investigation was carried out to examine the impact of various factors such as reaction time, sonication power, temperature, and reactant concentration on the morphology and size of the crystals. Interestingly, it was found that sonication power and temperature did not affect the crystals’ morphology and size. To further analyze the prepared microcrystals of MOCPs, SEM was utilized to examine their surface morphology, and XRD, elemental evaluation composition. The identification of the functional groups present in the prepared Mn-MOCPs was accomplished through the utilization of FT-IR spectroscopy. Subsequently, the calcination of 1 in an air atmosphere at 650 °C led to the formation of Mn3O4 nanoparticles. The geometric and electronic structure of the MOCPs was evaluated using density functional theory (DFT). The utilization of molecular docking methodologies demonstrated that the best cavity of the human androgen receptor possessed an interaction energy of −116.3 kJ mol−1. This energy encompassed a combination of both bonding and non-bonding interactions. The Results showed that steric interaction and electrostatic potential are the main interactions in AR polymer and Mn(II). These interactions in the defined cavity indicated that this polymer could be an effective anti-prostate candidate, because AR is involved in the growth of prostate cancer cells, and these interactions indicated the inhibition of prostate cancer cell growth.
Researchers Zohreh Mehrabadi (Not In First Six Researchers), Francis Verpoort (Not In First Six Researchers), Ghodrat Mahmoudi (Not In First Six Researchers), Werner Kaminsky (Not In First Six Researchers), Fazlolah Eshghi (Not In First Six Researchers), Bagher Souri (Not In First Six Researchers), Payam Hayati (Fifth Researcher), Paria Sharafi-Badr (Fourth Researcher), Nafiseh Pourshirband (Third Researcher), Fateme Firoozbakht (Second Researcher), Atash V. Gurbanov, (First Researcher)